The Novel Short Isoform of Securin Stimulates the Expression of Cyclin D3 and Angiogenesis Factors VEGFA and FGF2, but Does Not Affect the Expression of MYC Transcription Factor
- 作者: Demin D.E.1,2, Bogolyubova A.V.1,3, Zlenko D.V.3, Uvarova A.N.1,3, Deikin A.V.4, Putlyaeva L.V.1, Belousov P.V.1, Mitkin N.A.1, Korneev K.V.1,3, Sviryaeva E.N.1, Kulakovskiy I.V.1,5, Tatosyan K.A.1, Kuprash D.V.1,2,3, Schwartz A.M.1,2
-
隶属关系:
- Engelhardt Institute of Molecular Biology
- Moscow Institute of Physics and Technology
- Faculty of Biology
- Institute of Gene Biology
- Vavilov Institute of General Genetics
- 期: 卷 52, 编号 3 (2018)
- 页面: 436-445
- 栏目: Molecular Cell Biology
- URL: https://journals.rcsi.science/0026-8933/article/view/163552
- DOI: https://doi.org/10.1134/S0026893318030032
- ID: 163552
如何引用文章
详细
Pituitary tumor-transforming gene-1 (PTTG1) encodes securin, a multifunctional protein involved in development of various types of cancer. Securin participates in the regulation of sister chromatids separation and the expression of multiple genes involved in the control of the cell cycle, metabolism, and angiogenesis. In several human cell lines, we have found a novel short isoform of securin mRNA, which does not contain exons 3 and 4. After the translation of this new mRNA, a shortened protein is produced that, like the full-size form, is able to activate the transcription of cyclin D3 gene (CCND3), which controls the G1/S transition and angiogenesis factors VEGFA (vascular endothelial growth factor), and FGF2 (fibroblast growth factor 2) in HEK293 cells. However, unlike the full-size protein, the short isoform of PTTG1 does not affect the MYC gene expression because it lacks the DNA-binding domain, which is needed for its interactions with the MYC promoter. Furthermore, the short form of securin does not influence the expression of MYC transcriptional targets, such as TP53 and IL-8. Thus, we found a novel isoform of securin which is able to activate a more restricted repertoire of genes compared to the full-size protein.
作者简介
D. Demin
Engelhardt Institute of Molecular Biology; Moscow Institute of Physics and Technology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991; Dolgoprydny, Moscow oblast, 141701
A. Bogolyubova
Engelhardt Institute of Molecular Biology; Faculty of Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991; Moscow, 119234
D. Zlenko
Faculty of Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119234
A. Uvarova
Engelhardt Institute of Molecular Biology; Faculty of Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991; Moscow, 119234
A. Deikin
Institute of Gene Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119334
L. Putlyaeva
Engelhardt Institute of Molecular Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991
P. Belousov
Engelhardt Institute of Molecular Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991
N. Mitkin
Engelhardt Institute of Molecular Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991
K. Korneev
Engelhardt Institute of Molecular Biology; Faculty of Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991; Moscow, 119234
E. Sviryaeva
Engelhardt Institute of Molecular Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991
I. Kulakovskiy
Engelhardt Institute of Molecular Biology; Vavilov Institute of General Genetics
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991; Moscow, 119991
K. Tatosyan
Engelhardt Institute of Molecular Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991
D. Kuprash
Engelhardt Institute of Molecular Biology; Moscow Institute of Physics and Technology; Faculty of Biology
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991; Dolgoprydny, Moscow oblast, 141701; Moscow, 119234
A. Schwartz
Engelhardt Institute of Molecular Biology; Moscow Institute of Physics and Technology
编辑信件的主要联系方式.
Email: shvarec@yandex.ru
俄罗斯联邦, Moscow, 119991; Dolgoprydny, Moscow oblast, 141701
补充文件
